🇺🇸 FDA
Patent

US 10640771

Compositions and methods for treating and preventing macular degeneration

granted A61KA61K38/1793A61P

Quick answer

US patent 10640771 (Compositions and methods for treating and preventing macular degeneration) held by THE UNITED STATES OF AMERICA AS REPRESENTED BY THE expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE UNITED STATES OF AMERICA AS REPRESENTED BY THE
Grant date
Tue May 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K38/1793, A61P, A61P27/02